The Lancet, 0140-6736

Tidskrift

Fler filtreringsmöjligheter
  1. 2021
  2. HERA: a new era for health emergency preparedness in Europe?

    Simone Villa, Remko van Leeuwen, Claire Craig Gray, Marianne van der Sande, Flemming Konradsen, Günter Fröschl, David Gisselsson Nord, Clarissa Prazeres da Costa, Oriana Ramirez-Rubio, Ibrahim Abubakar, Till Bärnighausen, Núria Casamitjana, Astrid Berner-Rodoreda, Frank Cobelens, Antoni Plasència & Mario Raviglione, 2021 jun 5, I: The Lancet. 397, 10290, s. 2145-2147 3 s.

    Forskningsoutput: TidskriftsbidragLetter

  3. Identification of vulnerable plaques and patients by intracoronary near-infrared spectroscopy and ultrasound (PROSPECT II): a prospective natural history study

    David Erlinge, Akiko Maehara, Ori Ben-Yehuda, Hans Erik Bøtker, Michael Maeng, Lars Kjøller-Hansen, Thomas Engstrøm, Mitsuaki Matsumura, Aaron Crowley, Ovidiu Dressler, Gary S. Mintz, Ole Fröbert, Jonas Persson, Rune Wiseth, Alf Inge Larsen, Lisette Okkels Jensen, Jan Erik Nordrehaug, Øyvind Bleie, Elmir Omerovic, Claes Held & 5 andra, Stefan K. James, Ziad A. Ali, James E. Muller, Gregg W. Stone & PROSPECT II Investigators PROSPECT II Investigators, 2021, I: The Lancet. 397, 10278, s. 985-995 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  4. Mortality in STEMI patients without standard modifiable risk factors: a sex-disaggregated analysis of SWEDEHEART registry data

    Gemma A. Figtree, Stephen T. Vernon, Nermin Hadziosmanovic, Johan Sundström, Joakim Alfredsson, Clare Arnott, Vincent Delatour, Margrét Leósdóttir & Emil Hagström, 2021, I: The Lancet. 397, 10279, s. 1085-1094 10 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  5. Oral rimegepant for migraine prevention

    Lars Edvinsson, 2021, I: The Lancet. 397, 10268, s. 4-5 2 s.

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  6. 2020
  7. Mapping geographical inequalities in childhood diarrhoeal morbidity and mortality in low-income and middle-income countries, 2000-17: analysis for the Global Burden of Disease Study 2017

    Ali Kiadaliri, Robert C Reiner Jr & Local Burden of Disease Diarrhoea Collaborators Local Burden of Disease Diarrhoea Collaborators, 2020 maj 6, I: The Lancet. 395, s. 1779-1801 10239.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  8. Considerations and methods for placebo controls in surgical trials (ASPIRE guidelines)

    David J. Beard, Marion K. Campbell, Jane M. Blazeby, Andrew J. Carr, Charles Weijer, Brian H. Cuthbertson, Rachelle Buchbinder, Thomas Pinkney, Felicity L. Bishop, Jonathan Pugh, Sian Cousins, Ian A. Harris, L. Stefan Lohmander, Natalie Blencowe, Katie Gillies, Pascal Probst, Carol Brennan, Andrew Cook, Dair Farrar-Hockley, Julian Savulescu & 10 andra, Richard Huxtable, Amar Rangan, Irene Tracey, Peter Brocklehurst, Manuela L. Ferreira, Jon Nicholl, Barnaby C. Reeves, Freddie Hamdy, Samuel CS Rowley & Jonathan A. Cook, 2020, I: The Lancet. 395, 10226, s. 828-838 11 s.

    Forskningsoutput: TidskriftsbidragÖversiktsartikel

  9. COVID-19—a very visible pandemic

    Carina King, Lena Einhorn, Nele Brusselaers, Marcus Carlsson, Stefan Einhorn, Fredrik Elgh, Jonas Frisén, Åke Gustafsson, Stefan Hanson, Claudia Hanson, Thomas Hedner, Olle Isaksson, Anders Jansson, Åke Lundkvist, Jan Lötvall, Bo Lundback, Björn Olsen, Cecilia Söderberg-Nauclér, Anders Wahlin, Gunner Steineck & 1 andra, Anders Vahlne, 2020, I: The Lancet. 396, 10248, s. e15

    Forskningsoutput: TidskriftsbidragLetter

  10. Doing meaningful systematic reviews is no gravy train

    Jaap J. van Netten, Sicco A. Bus, Nicolaas C. Schaper, Jan Apelqvist & Benjamin A. Lipsky, 2020, I: The Lancet. 395, 10241, s. 1905-1906 2 s.

    Forskningsoutput: TidskriftsbidragLetter

  11. Ferric carboxymaltose for iron deficiency at discharge after acute heart failure: a multicentre, double-blind, randomised, controlled trial

    AFFIRM-AHF investigators AFFIRM-AHF investigators, Piotr Ponikowski, Marcus Ohlsson & Ewa A. Jankowska, 2020, I: The Lancet. 396, 10200, s. 1895-1904

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  12. Gendered effects of school closures during the COVID-19 pandemic

    Katarzyna Burzynska & Gabriela Contreras, 2020, I: The Lancet. 395, 10242, s. 1968-1968 1 s.

    Forskningsoutput: TidskriftsbidragLetter

  13. Understanding health spending for SDG 3

    Jesper Sundewall & Birger C. Forsberg, 2020, I: The Lancet. 396, 10252, s. 650-651 2 s.

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  14. 2019
  15. Percutaneous coronary intervention versus coronary artery bypass grafting in patients with three-vessel or left main coronary artery disease: 10-year follow-up of the multicentre randomised controlled SYNTAX trial

    Daniel J F M Thuijs, A Pieter Kappetein, Patrick W Serruys, Friedrich-Wilhelm Mohr, Marie-Claude Morice, Michael J Mack, David R Holmes, Nick Curzen, Piroze Davierwala, Thilo Noack, Milan Milojevic, Keith D Dawkins, Bruno R da Costa, Peter Jüni, Stuart J Head, Richard Ingemansson, Göran Olivecrona & SYNTAX Extended Survival Investigators SYNTAX Extended Survival Investigators, 2019 okt 12, I: The Lancet. 394, 10206, s. 1325-1334

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  16. 2-cm versus 4-cm surgical excision margins for primary cutaneous melanoma thicker than 2 mm: long-term follow-up of a multicentre, randomised trial

    Deborah Utjés, J. Malmstedt, Jüri Teras, Krzysztof Drzewiecki, Hans Petter Gullestad, Christian Ingvar, H. Eriksson & P. Gillgren, 2019 aug 10, I: The Lancet. 394, 10197, s. 471-477 7 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  17. Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer: 5-year outcomes of the HYPO-RT-PC randomised, non-inferiority, phase 3 trial

    Anders Widmark, Adalsteinn Gunnlaugsson, Lars Beckman, Camilla Thellenberg-Karlsson, Morten Hoyer, Magnus Lagerlund, Jon Kindblom, Claes Ginman, Bengt Johansson, Kirsten Björnlinger, Mihajl Seke, Måns Agrup, Per Fransson, Björn Tavelin, David Norman, Björn Zackrisson, Harald Anderson, Elisabeth Kjellén, Lars Franzén & Per Nilsson, 2019 aug 3, I: The Lancet. 394, 10196, s. 385-395 11 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  18. Lessons from Sweden’s feminist foreign policy for global health

    Rachel Irwin, 2019 feb, I: The Lancet. 393, 10171, s. e27-e28

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  19. Screening for abdominal aortic aneurysm

    Anders Wanhainen, Sverker Svensjö, Jan Holst, Martin Björck, Anders Gottsäter & Swedish Aneurysm Screening Study Group Swedish Aneurysm Screening Study Group, 2019 jan 5, I: The Lancet. 393, 10166, s. 27-28

    Forskningsoutput: TidskriftsbidragLetter

  20. NIRS-intravascular imaging to predict coronary events

    David Erlinge, 2019, I: The Lancet. 394, 10209, s. 1594-1595 2 s.

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  21. Rimegepant oral disintegrating tablet for migraine

    Lars Edvinsson, 2019, I: The Lancet. 394, 10200, s. 711-712 2 s.

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

  22. 2018
  23. Global, regional, and national age-sex-specific mortality and life expectancy, 1950-2017: a systematic analysis for the Global Burden of Disease Study 2017

    Aliasghar Ahmad Kiadaliri & GBD 2017 Mortality Collaborators GBD 2017 Mortality Collaborators, 2018 nov 10, I: The Lancet. 392, 10159, s. 1684-1735 52 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  24. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017

    Aliasghar Ahmad Kiadaliri & GBD 2017 Causes of Death Collaborators GBD 2017 Causes of Death Collaborators, 2018 nov 10, I: The Lancet. 392, 10159, s. 1736-1788 53 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  25. Global, regional, and national disability-adjusted life-years (DALYs) for 359 diseases and injuries and healthy life expectancy (HALE) for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

    Aliasghar Ahmad Kiadaliri & GBD 2017 DALYs and HALE Collaborators GBD 2017 DALYs and HALE Collaborators, 2018 nov 10, I: The Lancet. 392, 10159, s. 1859-1922

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  26. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017

    Aliasghar Ahmad Kiadaliri & GBD 2017 Disease and Injury Incidence and Prevalence Collaborators GBD 2017 Disease and Injury Incidence and Prevalence Collaborators, 2018 nov 10, I: The Lancet. 392, 10159, s. 1789-1858 70 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  27. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017

    Aliasghar Ahmad Kiadaliri & GBD 2017 SDG Collaborators GBD 2017 SDG Collaborators, 2018 nov 10, I: The Lancet. 392, 10159, s. 2091-2138 48 s.

    Forskningsoutput: TidskriftsbidragArtikel i vetenskaplig tidskrift

  28. Beyond precision: embracing the politics of global health numbers

    Morten Jerven, 2018 aug, I: The Lancet. 392, 10146, s. 468-469 2 s.

    Forskningsoutput: TidskriftsbidragDebate/Note/Editorial

Föregående 1 2 3 4 5 6 7 8 9 Nästa